{
    "clinical_study": {
        "@rank": "92317", 
        "acronym": "REVECOL", 
        "arm_group": {
            "arm_group_label": "reventilation collapse"
        }, 
        "brief_summary": {
            "textblock": "Prospective, observational clinical multicentric study in ICU; during the period surrounding\n      the orotracheal intubation."
        }, 
        "brief_title": "Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Arterial Line", 
            "Consent of Patients", 
            "Adult Patients", 
            "Tracheal Intubation in ICU"
        ], 
        "condition_browse": {
            "mesh_term": "Shock"
        }, 
        "detailed_description": {
            "textblock": "Main objective: to describe the characteristics of reventilation collapse: collapse rate,\n      duration and treatment implemented\n\n      Secondary objectives:\n\n        -  identify risk factors of reventilation collapse\n\n        -  compare mortality, hemodynamic, respiratory, infectious and biological data between\n           collapse group and no reventilation collapse group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Arterial line\n\n          -  Consent of patients\n\n          -  Adult patients\n\n          -  Tracheal intubation in ICU\n\n        Exclusion Criteria:\n\n          -  tracheal intubation for cardiac arrest\n\n          -  pregnant woman\n\n          -  major protected"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Defined population"
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785654", 
            "org_study_id": "CHU-0142", 
            "secondary_id": "DC-2012-1501"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Reventilation collapse", 
            "Rate of reventilation collapse", 
            "Risk factor of reventilation collapse", 
            "Hemodynamic profile of reventilation collapse", 
            "Biologic approach of reventilation collapse"
        ], 
        "lastchanged_date": "February 5, 2013", 
        "location": {
            "contact": {
                "email": "placarin@chu-clermontferrand.fr", 
                "last_name": "Patrick LACARIN", 
                "phone": "04 73 75 11 95"
            }, 
            "facility": {
                "address": {
                    "city": "Clermont-Ferrand", 
                    "country": "France", 
                    "zip": "63003"
                }, 
                "name": "CHU Clermont-Ferrand"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU", 
        "overall_contact": {
            "email": "placarin@chu-clermontferrand.fr", 
            "last_name": "Patrick LACARIN", 
            "phone": "04 73 75 11 95"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Clermont-Ferrand", 
            "last_name": "Sebastien PERBET", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Reventilation collapse", 
            "safety_issue": "No", 
            "time_frame": "at day 1 (at least thirty minutes despite 500 or 1000ml of fluid resuscitation)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785654"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "reventilation collapse", 
                "safety_issue": "No", 
                "time_frame": "in the last 72 hours"
            }, 
            {
                "measure": "Duration of mechanical ventilation", 
                "safety_issue": "No", 
                "time_frame": "at day 1"
            }, 
            {
                "measure": "mortality", 
                "safety_issue": "No", 
                "time_frame": "at day 28"
            }
        ], 
        "source": "University Hospital, Clermont-Ferrand", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Clermont-Ferrand", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}